The popularity of any investment trust, and hence the discount or premium to net asset value (NAV) at which its shares trade, ought in theory to reflect its historic performance and its prospects for the future. Investors, however, are far from rational. A trust that has grown its NAV by 251% in 10 years, doubling it in five, compared with the FTSE All-World index’s total return of 138%, ought to be a market darling. But the shares of HarbourVest Global Private Equity (LSE: HVPE) trade at a discount of over 40%.
Doesn’t that suggest that its portfolio is massively overvalued? That argument might be plausible if stock markets had crashed, the world was facing recession, valuations were defying gravity and disposals had ground to a halt. But markets have been rising steadily against a benign economic backdrop. The average valuation multiple for a representative sample of the portfolio at year-end was a reasonable 14 times cash flow, average cash flow having increased 15% in the year.
A conservative valuation
In the year to 31 January 2024, around 10% of the portfolio was sold at an average premium to carrying value of 24%, which suggests that the portfolio valuation is conservative. A conservative valuation makes it easy to continue generating uplifts in the future. One of HVPE’s largest investments, accounting for 2.1% of the portfolio, is Chinese fast-fashion group Shein, expected to list in London soon.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Why, then, doesn’t HVPE buyback shares at such a discount? Actually, it has been doing so since September 2022, having bought back 2.9 million shares, nearly 4% of those in issue, and contributing 86 cents to an NAV of $50.47. The board has allocated $150 million-$250 million to a buyback pool, which JPMorgan estimates would add 2.9% to 5.2% to NAV at current prices. Are the shares illiquid? No, the market value of HVPE is £1,840 million. Are costs high? Total expenses in the year were 1.8% of the average NAV, of which one-third was incurred in the underlying funds. Managing private equity is expensive, with costs more comparable to a listed company than to a fund investing in listed shares, but the returns are significantly higher.
HVPE invests via 63 funds managed by HarbourVest Partners and also in 16 co-investments. As a result, with 1,334 companies in the underlying portfolio, it is very well diversified. This means that there is little visibility of the underlying holdings, but the impact from individual problem companies will be very low. Investors appear to think the former matters more than the latter, but it is not obvious why. HVPE’s peer group of “fund-of-fund” private-equity trusts trades on an average discount to NAV of 35% (HVPE’s is the highest), with an average five-year return of 96% (HVPE’s is the second-highest). There are other private-equity trusts with better records than HVPE, but trading on a lower discount. There are some on higher discounts but with terrible performance records.
James Glass of Numis Securities points out that “in the UK, private equity... polarises opinion with a widespread view that it represents a culture of ‘greed is good’. As a result, benchmarks for personal, charitable and institutional investment have no allocation to it”. The UK’s aversion is both unique and irrational, given that “listed private equity consistently outperforms public equity, net of fees, by an average 6.25% per annum”.
Listed private equity provides investors access to an outperforming asset class that they could not access directly, with good liquidity at bargain basement prices. Within a very undervalued sector, the combination of HVPE’s very strong performance record and inexplicably high discount is hard to beat – especially with the board trying to narrow the discount and add to NAV by buying back shares.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

Max has an Economics degree from the University of Cambridge and is a chartered accountant. He worked at Investec Asset Management for 12 years, managing multi-asset funds investing in internally and externally managed funds, including investment trusts. This included a fund of investment trusts which grew to £120m+. Max has managed ten investment trusts (winning many awards) and sat on the boards of three trusts – two directorships are still active.
After 39 years in financial services, including 30 as a professional fund manager, Max took semi-retirement in 2017. Max has been a MoneyWeek columnist since 2016 writing about investment funds and more generally on markets online, plus occasional opinion pieces. He also writes for the Investment Trust Handbook each year and has contributed to The Daily Telegraph and other publications. See here for details of current investments held by Max.
-
Hargreaves Lansdown shakes up fees in biggest change in 10 years – what does it mean for you?Hargreaves Lansdown is lowering its headline fee from 0.45% to 0.35% – but not everyone will be happy with the new fee structure, it’s been suggested.
-
Michael Moritz: The richest Welshman to walk the EarthMichael Moritz started out as a journalist before catching the eye of a Silicon Valley titan. He finds Donald Trump to be “an absurd buffoon”
-
Three promising emerging-market stocks to diversify your portfolioOpinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
-
Coface offers excess profit in an unloved sectorCoface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotechBiotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
How to invest in the new breed of payment providersUpstart payment providers are taking the world by storm. It’s time for investors to buy in, says Rupert Hargreaves
-
What turns a stock market crash into a financial crisis?Opinion Professor Linda Yueh's popular book on major stock market crashes misses key lessons, says Max King
-
How to add cryptocurrency to your portfolioA new listing shows how bitcoin might add value to a portfolio if cryptocurrency keeps gaining acceptance, says Cris Sholto Heaton
-
Profit from pest control with Rentokil InitialRentokil Initial is set for global expansion and offers strong sales growth
-
Three funds to buy for capital growth and global incomeOpinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust